NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 378 filers reported holding NOVAVAX INC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,484,924 | -15.0% | 205,100 | -12.8% | 0.10% | -10.2% |
| Q2 2023 | $1,747,536 | +236.2% | 235,200 | +213.6% | 0.11% | +217.6% |
| Q1 2023 | $519,750 | -67.6% | 75,000 | -51.9% | 0.03% | -62.6% |
| Q4 2022 | $1,603,680 | +9.0% | 156,000 | +92.8% | 0.09% | +31.9% |
| Q3 2022 | $1,471,000 | -79.2% | 80,900 | -41.2% | 0.07% | -76.0% |
| Q2 2022 | $7,072,000 | +48.4% | 137,524 | +112.6% | 0.29% | +66.5% |
| Q1 2022 | $4,765,000 | -71.6% | 64,700 | -44.7% | 0.17% | -71.0% |
| Q4 2021 | $16,750,000 | -40.8% | 117,078 | -14.2% | 0.60% | -50.5% |
| Q3 2021 | $28,302,000 | -10.4% | 136,520 | -8.3% | 1.20% | -8.0% |
| Q2 2021 | $31,591,000 | +3.1% | 148,800 | -11.9% | 1.31% | +3.7% |
| Q1 2021 | $30,634,000 | +49.5% | 168,964 | -8.0% | 1.26% | +60.4% |
| Q4 2020 | $20,486,000 | +28.7% | 183,700 | +25.0% | 0.79% | +4.4% |
| Q3 2020 | $15,919,000 | +89.6% | 146,921 | +45.9% | 0.75% | +58.5% |
| Q2 2020 | $8,394,000 | – | 100,700 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |